WASHINGTON (CN) - Carnegie Mellon University's patent lawsuit was properly denied due to lack of a written description, the Federal Circuit ruled.
Carnegie Mellon and Three Rivers Biologicals sued Hoffman-La Roche, alleging infringement of its patent on a method of gene cloning to produce synthetic proteins.
Judge Lourie ruled that in a proper written description, it was not enough for Carnegie Mellon to state the biotechnical genus.
"A specification must describe the claimed invention in such a way that a person of skill in the art would understand that the genus that is being claimed has been invented, not just the species of a genus."
Subscribe to Closing Arguments
Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.